OPKO Health Files 8-K: Material Agreement & Equity Sales
Ticker: OPK · Form: 8-K · Filed: Mar 28, 2025 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, sec-filing
TL;DR
OPKO Health inked a big deal and sold some stock, filing an 8-K today.
AI Summary
On March 27, 2025, OPKO Health, Inc. entered into a material definitive agreement and reported unregistered sales of equity securities. The company, incorporated in Delaware with its principal executive offices in Miami, Florida, filed this 8-K report on March 28, 2025.
Why It Matters
This filing indicates significant corporate actions, including a new material agreement and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions both a material definitive agreement and unregistered sales of equity, which can introduce complexities and potential risks related to financing and shareholder dilution.
Key Numbers
- 001-33528 — SEC File Number (Identifies the company's filing with the SEC.)
- 75-2402409 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- OPKO Health, Inc. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- March 28, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- Miami, Florida (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by OPKO Health, Inc. on March 27, 2025?
The filing states that OPKO Health, Inc. entered into a material definitive agreement on March 27, 2025, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold unregistered by OPKO Health, Inc.?
The filing mentions unregistered sales of equity securities, but the specific type and details of these securities are not disclosed in the provided text.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on March 28, 2025.
Where are OPKO Health, Inc.'s principal executive offices located?
OPKO Health, Inc.'s principal executive offices are located at 4400 Biscayne Blvd., Miami, Florida 33137.
What are the previous names of OPKO Health, Inc. mentioned in the filing?
The filing mentions that OPKO Health, Inc. was formerly known as Opko Health, Inc. (after a name change on 20070621), eXegenics Inc (after a name change on 20040505), and EXEGENICS INC (after a name change on 20011114).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding OPKO HEALTH, INC. (OPK).